Uterine size and risk of complications among women undergoing abdominal hysterectomy for leiomyomas

被引:57
作者
Hillis, SD
Marchbanks, PA
Peterson, HB
机构
[1] Division of Reproductive Health, Natl. Ctr. Chron. Dis. Prev. H., Centers for Dis. Contr. and Prev., Atlanta, GA
[2] Centers for Dis. Contr. and Prev., NCCDPHP/DRH, K-34, Atlanta
关键词
D O I
10.1016/0029-7844(95)00478-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To measure the influence of uterine size on the risk of operative complications among women undergoing abdominal hysterectomy for uterine leiomyomas. Methods: Four hundred forty-six women undergoing abdominal hysterectomy for pathologically confirmed leiomyomas were analyzed using data from a previously reported prospective cohort study. We compared the risk of operative complications among women with uterine weights less than 250 g, 251-500 g, and greater than 500 g. Logistic regression was used to estimate the independent effect of uterine size on the probability of operative complications. Results: The risk of blood transfusion increased with increasing uterine weight; 13.7, 14.2, and 26.7% of women with uterine weight less than 250 g, 251-500 gr and greater than 500 g, respectively, required transfusion (P for trend < .05). After adjustment for race, previous surgery, preoperative weight, concurrent endometriosis, and type of insurance coverage, women with uterine weight greater than 500 g had increased odds of having a transfusion (odds ratio [OR] 2.4, 95% confidence interval [CI] 1.3-4.3). These women also had increased odds of having an estimated blood loss greater than 500 mt (OR 2.5, 95% CI 1.5-4.2), vaginal cuff cellulitis (OR 2.8, 95% CI 1.3-6.2), and at least one of a number of operative complications (OR 1.6, 95% CI 1.0-4.0). Conclusion: Women with leiomyomas whose uterine weight exceeds 500 g have an increased risk of complications from abdominal hysterectomy.
引用
收藏
页码:539 / 543
页数:5
相关论文
共 20 条
[1]   DEFERRED VERSUS IMMEDIATE SURGERY FOR UTERINE FIBROIDS - CLINICAL-TRIAL RESULTS [J].
AUDEBERT, AJM ;
MADENELAT, P ;
QUERLEU, D ;
PONTONNIER, G ;
RACINET, C ;
RENAUD, R ;
GILLET, JY ;
RAUDRANT, D ;
LANSAC, J ;
BRETTES, JP .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 :29-32
[2]   FIBROIDS - OVERVIEW OF CURRENT AND FUTURE TREATMENT OPTIONS [J].
BENAGIANO, G ;
MORINI, A ;
PRIMIERO, FM .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1992, 99 :18-22
[3]   USE OF GNRH AGONIST BEFORE HYSTERECTOMY - A COST SIMULATION [J].
BRADHAM, DD ;
STOVALL, TG ;
THOMPSON, CD .
OBSTETRICS AND GYNECOLOGY, 1995, 85 (03) :401-406
[4]  
CARLSON KJ, 1993, NEW ENGL J MED, V328, P856
[5]   THE MAINE-WOMENS-HEALTH-STUDY .1. OUTCOMES OF HYSTERECTOMY [J].
CARLSON, KJ ;
MILLER, BA ;
FOWLER, FJ .
OBSTETRICS AND GYNECOLOGY, 1994, 83 (04) :556-565
[6]   COMPLICATIONS OF ABDOMINAL AND VAGINAL HYSTERECTOMY AMONG WOMEN OF REPRODUCTIVE AGE IN THE UNITED-STATES [J].
DICKER, RC ;
GREENSPAN, JR ;
STRAUSS, LT ;
COWART, MR ;
SCALLY, MJ ;
PETERSON, HB ;
DESTEFANO, F ;
RUBIN, GL ;
ORY, HW .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 144 (07) :841-848
[7]  
DROEGEMUELLER W, 1992, COMPREHENSIVE GYNECO, P491
[8]  
FLICKINGER L, 1986, OBSTET GYNECOL, V68, P855
[9]   SHOULD UTERINE SIZE BE AN INDICATION FOR SURGICAL INTERVENTION IN WOMEN WITH MYOMAS [J].
FRIEDMAN, AJ ;
HAAS, ST .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (03) :751-755
[10]  
GAMBONE JC, 1989, OBSTET GYNECOL, V73, P1045